Medical Cannabis Studies


• addiction (10)

• alzheimers/dementia (14)

• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)

• antibacterial (6)

• antioxidant (8)

• antiprion (1)

• anxiety (10)

• appetite (4)

• arthritis (4)

• asthma (1)

• attention-deficit-hyperactivity-disorder-adhd (5)

• autism (11)

• autoimmune (3)


• batten-disease (6)

• benefits (9)

• breast-cancer (7)


• cancer (94)

• cannabidiol-cbd (8)

• cardiovascular (8)

• cb1-receptor (8)

• cb2-receptor (9)

• cellular-function (4)

• cerebral-palsy (1)

• cognition (2)

• colon-cancer (8)


• d9-tetrahydrocannabinol-thc (4)

• d9-tetrahydrocannabinolic-acid-thca (1)

• diabetes (4)

• drug-interactions (2)


• emesis (6)

• endocannabinoid-system-ecs (45)

• endocrine-system (3)

• epilepsy (30)


• fibromyalgia (2)

• fibrosis (1)


• gastrointestinal-disease (6)

• general (20)

• glaucoma (1)

• glioblastoma (1)

• glioma (9)


• health-care (1)

• hiv (7)

• huntingtons-disease (1)


• immune-function (8)

• infant-development (1)

• inflammation (9)

• ischemia (3)


• krabbe-disease (4)


• liver (2)

• lung-cancer (2)

• lupus (1)


• memory (3)

• mental-illness (14)

• migraine (1)

• mitochondria (1)

• multiple-sclerosis (15)


• national-institute-on-drug-abuse-nida (1)

• nausea (1)

• nervous-system (4)

• neuro-protective-and-neuro-generative (7)


• pain (29)

• pancreatitis (1)

• prostate-cancer (2)


• schizophrenia (2)

• skin (1)

• sports (3)


• thc (1)

• therapeutic (1)

• traumatic-brain-injury-tbi (1)

• View All (505)
  • Association of the Cannabinoid Receptor Gene (CNR1) With ADHD and Post-Traumatic Stress Disorder (2009)

    These observations suggest that the cannabinoid receptor gene (CNR1) may be a risk factor for ADHD and possibly TTPT, and that this gene deserves further investigation for a role in neuropsychiatric disorders. View study

  • Associations between Adolescent Cannabis Use and Neuropsychological Decline (no year)

    This study focused on the associations between cannabis use in adolescents and the neuropsychological decline. According to the results, it could be concluded that the short-term use of cannabis in adolescence does not seem to cause a decrease in the IQ or alter executive functions, even when cannabis use reaches the level of dependence. View study

  • Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling (2013)

    Neuroligin-3 is specifically necessary for tonic endocannabinoid signaling. This suggests that alterations in endocannabinoid signaling may contribute to the pathophysiology of autism. View study

  • Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (2013)

    According to the results obtained using mice as a sample, the positive effect of cannabigerol (CBG), a cannabinoid derivative of non-psychotropic cannabis, in a murine model of colitis could be verified. Its use is possible for the treatment of patients with inflammatory bowel disease (IBD). Because CBG attenuated murine colitis, it reduced the production of nitric oxide in macrophages (effect modulated by the CB2 receptor) and reduced ROS formation in intestinal epithelial cells View study

  • Benefits and adverse effects of cannabis use among adults with persistent pain (2018)

    Increasingly, states are legalizing cannabis for recreational use. Improved accessibility can allow adults with pain to use cannabis more liberally. The purpose of this study was to examine the perceived effects of cannabis in adults who have been prescribed opioids for persistent pain. View study

  • Benefits and Harms of Cannabis in Chronic Pain or Post-traumatic Stress Disorder: A Systematic Review [Internet] (2017)

    Recent studies indicate that between 45% and 80% of people who seek cannabis for medical purposes do so to control pain, which suggests its therapeutic potential in patients with chronic pain. View study

  • Biphasic Effects of Cannabinoids on Acetylcholine Release in the Hippocampus: Site and Mechanism of Action (2003)

    This research was based on the study of the biphasic effects of cannabinoids on the release of acetylcholine in the hippocampus, site and mechanism of action. The results found in this study could help and provide a theoretical framework for understanding endocannabinoids as modulators of neuronal activity dependent on the state. View study

  • Blood pressure regulation by endocannabinoids and their receptors (2005)

    This research focuses on analyzing the in vivo hypotensive and cardiodepressant effects of cannabinoids mediated by cannabinoid and TRPV1 receptors and new therapeutic strategies related to the treatment of hypertension. View study

  • Brain CB2 Receptors: Implications for Neuropsychiatric Disorders (2010)

    The CB2 receptor as a possible target for the treatment of neuroinflammatory and neurodegenerative disorders. View study

  • Can You Pass the Acid Test? Critical Review and Novel Therapeutic Perspectives of D9-Tetrahydrocannabinolic Acid A.pdf (2016)

    This study seeks to make a critical analysis and offer new therapeutic perspectives of D9-tetrahydrocannabinolic acid View study

  • Canabimimetic plants: are they new cannabinoidergic modulators. (2019)

    The objective of this review was to provide critical and complete assessment of the botanical, chemical and therapeutic aspects of cannabimimetic plants to evaluate their spread in the world and medicinal potentiality. View study

  • Cannabidiol (CBD) and its analogs: A review of their effects on inflammation (2015)

    Until 1963 the structure of the CBD was not completely elucidated, and THC was thought to be the most powerful and active component of cannabis, a belief that was mostly due to its psychoactive effects. Therefore, the therapeutic benefits of CBD were minimized for a long time. This study focuses on the therapeutic and anti-inflammatory benefits of CBD. View study